Population pharmacokinetic models. Measures of central tendency

W. F. Dodge, R. W. Jelliffe, Carol Richardson, R. A. Bellanger, J. A. Hokanson, W. R. Snodgrass

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The availability of personal computer programs for individualising drug dosage regimens has stimulated interest in modelling population pharmacokinetics. Appropriate use of population models requires knowledge of the distribution of their pharmacokinetic parameter values. If non-Gaussian, it is imperative not to assume that the arithmetic mean is the best measure of central tendency. This has important consequences for therapeutic drug monitoring and for individualising drug dosage regimens. Utilising a new nonparametric expectation maximisation (NPEM) population modelling program and retrospective data from 129 preterm infants who received gentamicin in our own clinical setting, we developed 2 population models. The NPEM algorithm showed that both had significant non-Gaussian distributions of their parameter values (e.g. the mean value for the volume of distribution exceeded the 75th percentile). Although the median parameter values demonstrated only slightly better predictive accuracy than the mean, its choice as the measure of central tendency was associated with excellent agreement between the goal and the subsequently observed average initial peak serum gentamicin concentrations (i.e. 6.0 vs 6.2 mg/L). In contrast, simulation using the mean parameter values predicted an average concentration 30% greater than the goal (i.e. 8.0 vs 6.0 mg/L). Thus, for this group of patients, the median proved a better measure of central tendency.

Original languageEnglish (US)
Pages (from-to)206-211
Number of pages6
JournalDrug Investigation
Volume5
Issue number4
StatePublished - 1993

Fingerprint

Pharmacokinetics
Gentamicins
Population
Population Control
Drug Monitoring
Microcomputers
Premature Infants
Pharmaceutical Preparations
Software
Serum

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Dodge, W. F., Jelliffe, R. W., Richardson, C., Bellanger, R. A., Hokanson, J. A., & Snodgrass, W. R. (1993). Population pharmacokinetic models. Measures of central tendency. Drug Investigation, 5(4), 206-211.

Population pharmacokinetic models. Measures of central tendency. / Dodge, W. F.; Jelliffe, R. W.; Richardson, Carol; Bellanger, R. A.; Hokanson, J. A.; Snodgrass, W. R.

In: Drug Investigation, Vol. 5, No. 4, 1993, p. 206-211.

Research output: Contribution to journalArticle

Dodge, WF, Jelliffe, RW, Richardson, C, Bellanger, RA, Hokanson, JA & Snodgrass, WR 1993, 'Population pharmacokinetic models. Measures of central tendency', Drug Investigation, vol. 5, no. 4, pp. 206-211.
Dodge WF, Jelliffe RW, Richardson C, Bellanger RA, Hokanson JA, Snodgrass WR. Population pharmacokinetic models. Measures of central tendency. Drug Investigation. 1993;5(4):206-211.
Dodge, W. F. ; Jelliffe, R. W. ; Richardson, Carol ; Bellanger, R. A. ; Hokanson, J. A. ; Snodgrass, W. R. / Population pharmacokinetic models. Measures of central tendency. In: Drug Investigation. 1993 ; Vol. 5, No. 4. pp. 206-211.
@article{bf0dbc05260c4b03920577f15a0dd496,
title = "Population pharmacokinetic models. Measures of central tendency",
abstract = "The availability of personal computer programs for individualising drug dosage regimens has stimulated interest in modelling population pharmacokinetics. Appropriate use of population models requires knowledge of the distribution of their pharmacokinetic parameter values. If non-Gaussian, it is imperative not to assume that the arithmetic mean is the best measure of central tendency. This has important consequences for therapeutic drug monitoring and for individualising drug dosage regimens. Utilising a new nonparametric expectation maximisation (NPEM) population modelling program and retrospective data from 129 preterm infants who received gentamicin in our own clinical setting, we developed 2 population models. The NPEM algorithm showed that both had significant non-Gaussian distributions of their parameter values (e.g. the mean value for the volume of distribution exceeded the 75th percentile). Although the median parameter values demonstrated only slightly better predictive accuracy than the mean, its choice as the measure of central tendency was associated with excellent agreement between the goal and the subsequently observed average initial peak serum gentamicin concentrations (i.e. 6.0 vs 6.2 mg/L). In contrast, simulation using the mean parameter values predicted an average concentration 30{\%} greater than the goal (i.e. 8.0 vs 6.0 mg/L). Thus, for this group of patients, the median proved a better measure of central tendency.",
author = "Dodge, {W. F.} and Jelliffe, {R. W.} and Carol Richardson and Bellanger, {R. A.} and Hokanson, {J. A.} and Snodgrass, {W. R.}",
year = "1993",
language = "English (US)",
volume = "5",
pages = "206--211",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Population pharmacokinetic models. Measures of central tendency

AU - Dodge, W. F.

AU - Jelliffe, R. W.

AU - Richardson, Carol

AU - Bellanger, R. A.

AU - Hokanson, J. A.

AU - Snodgrass, W. R.

PY - 1993

Y1 - 1993

N2 - The availability of personal computer programs for individualising drug dosage regimens has stimulated interest in modelling population pharmacokinetics. Appropriate use of population models requires knowledge of the distribution of their pharmacokinetic parameter values. If non-Gaussian, it is imperative not to assume that the arithmetic mean is the best measure of central tendency. This has important consequences for therapeutic drug monitoring and for individualising drug dosage regimens. Utilising a new nonparametric expectation maximisation (NPEM) population modelling program and retrospective data from 129 preterm infants who received gentamicin in our own clinical setting, we developed 2 population models. The NPEM algorithm showed that both had significant non-Gaussian distributions of their parameter values (e.g. the mean value for the volume of distribution exceeded the 75th percentile). Although the median parameter values demonstrated only slightly better predictive accuracy than the mean, its choice as the measure of central tendency was associated with excellent agreement between the goal and the subsequently observed average initial peak serum gentamicin concentrations (i.e. 6.0 vs 6.2 mg/L). In contrast, simulation using the mean parameter values predicted an average concentration 30% greater than the goal (i.e. 8.0 vs 6.0 mg/L). Thus, for this group of patients, the median proved a better measure of central tendency.

AB - The availability of personal computer programs for individualising drug dosage regimens has stimulated interest in modelling population pharmacokinetics. Appropriate use of population models requires knowledge of the distribution of their pharmacokinetic parameter values. If non-Gaussian, it is imperative not to assume that the arithmetic mean is the best measure of central tendency. This has important consequences for therapeutic drug monitoring and for individualising drug dosage regimens. Utilising a new nonparametric expectation maximisation (NPEM) population modelling program and retrospective data from 129 preterm infants who received gentamicin in our own clinical setting, we developed 2 population models. The NPEM algorithm showed that both had significant non-Gaussian distributions of their parameter values (e.g. the mean value for the volume of distribution exceeded the 75th percentile). Although the median parameter values demonstrated only slightly better predictive accuracy than the mean, its choice as the measure of central tendency was associated with excellent agreement between the goal and the subsequently observed average initial peak serum gentamicin concentrations (i.e. 6.0 vs 6.2 mg/L). In contrast, simulation using the mean parameter values predicted an average concentration 30% greater than the goal (i.e. 8.0 vs 6.0 mg/L). Thus, for this group of patients, the median proved a better measure of central tendency.

UR - http://www.scopus.com/inward/record.url?scp=0027470043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027470043&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027470043

VL - 5

SP - 206

EP - 211

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 4

ER -